Clinic of Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy.
Division of Immunology, Transplantation and Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy.
Front Immunol. 2020 Oct 2;11:580867. doi: 10.3389/fimmu.2020.580867. eCollection 2020.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is primarily diagnosed through viral RNA positivity in nasopharyngeal swabs, and it is associated with the early detection of specific immunoglobulins to SARS-CoV-2 proteins. We describe two moderate coronavirus disease 2019 (COVID-19) patients with WHO score 4/5 at the time of hospitalization, pneumonia, and oxygen saturation <94% and with a strong discrepancy between viral RNA and antibodies to SARS-CoV-2. One patient was positive for viral RNA but completely negative for binding and neutralizing antibodies, whereas the second patient was negative for viral RNA but with high levels of both neutralizing and binding antibodies. This observation is relevant to better understand the pathogenesis of this novel infection.
严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染主要通过鼻咽拭子中病毒 RNA 的阳性来诊断,并且与 SARS-CoV-2 蛋白的特异性免疫球蛋白的早期检测相关。我们描述了 2 例中度 2019 年冠状病毒病(COVID-19)患者,他们在住院时世界卫生组织(WHO)评分为 4/5,患有肺炎,氧饱和度<94%,并且病毒 RNA 与 SARS-CoV-2 抗体之间存在明显差异。其中 1 例患者病毒 RNA 阳性,但结合抗体和中和抗体均完全阴性,而第 2 例患者病毒 RNA 阴性,但中和抗体和结合抗体水平均很高。这一观察结果有助于更好地了解这种新型感染的发病机制。